<i> <i>DNMT3A</i> </i> Mutant Clonal Hematopoiesis in Vexas Syndrome Epigenetically Potentiates IL-13 and IL-15 Inflammatory Pathways and Is Associated with Increased Mortality
Jenna Fernandez(Mayo Clinic), Mrinal M. Patnaik(Mayo Clinic), Terra L. Lasho(Mayo Clinic), Abhishek A. Mangaonkar(Mayo Clinic), Matthew J. Koster(Mayo Clinic in Arizona), Wazim Mohammed Ismail(Mayo Clinic), Horatiu Olteanu(Mayo Clinic in Arizona), Alexander Hines(WinnMed), Kenneth J. Warrington(Mayo Clinic), Emma M. Groarke(MACOM (United States)), David B. Beck(Center for Human Genetics), Alexandre Gaspar‐Maia(Mayo Clinic), Yael Kusne(WinnMed), Christy M. Finke(Mayo Clinic), Kaaren K. Reichard(Mayo Clinic), Bhavisha A. Patel(MACOM (United States)), Fernanda Gutierrez‐Rodrigues(National Heart Lung and Blood Institute), Rong He(Mayo Clinic in Arizona), Megan M. Sullivan(Mayo Clinic in Arizona), Kambiz Kalantari(Mayo Clinic), Neal S. Young(National Institutes of Health), Naseema Gangat(Mayo Clinic in Arizona), David S. Viswanatha(Mayo Clinic), Daniel Montes(WinnMed)
Cited by 1
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
|Blood|2011|448
Inherited antithrombin deficiency: a review
|Haemophilia|2008|396